Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14868]

ASCO GU 2023: Polymerase inhibitor significantly improves progression-free survival for metastatic prostate cancer

ASCO GU 2023: Polymerase inhibitor significantly improves progression-free survival for metastatic prostate cancer

Ponatinib more effective than imatinib for newly diagnosed Ph+ALL leukaemia patients

Ponatinib more effective than imatinib for newly diagnosed Ph+ALL leukaemia patients

ASCO GU 2023: Diet higher in plants associated with lower risk of prostate cancer progression and recurrence

ASCO GU 2023: Diet higher in plants associated with lower risk of prostate cancer progression and recurrence

ASCO GU 2023: Update on bladder-sparing treatment trial: RETAIN BLADDER

ASCO GU 2023: Update on bladder-sparing treatment trial: RETAIN BLADDER

Study confirms pancreatic cancer rates rising faster in women than men

Study confirms pancreatic cancer rates rising faster in women than men

Lack of resources is associated with increased mortality in childhood cancer survivors

Lack of resources is associated with increased mortality in childhood cancer survivors

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

For children with cancer, different neighborhoods may produce different outcomes for different races

For children with cancer, different neighborhoods may produce different outcomes for different races

Improving treatment for recurrent multiple myeloma with ide-cel CAR T therapy

Improving treatment for recurrent multiple myeloma with ide-cel CAR T therapy

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

More from ecancer